Veroutis Dimitris, Argyropoulou Ourania D, Goules Andreas V, Kambas Konstantinos, Palamidas Dimitris Anastasios, Evangelou Konstantinos, Havaki Sophia, Polyzou Aikaterini, Valakos Dimitrios, Xingi Evangelia, Karatza Elli, Boki Kyriaki A, Cavazza Alberto, Kittas Christos, Thanos Dimitris, Ricordi Caterina, Marvisi Chiara, Muratore Francesco, Galli Elena, Croci Stefania, Salvarani Carlo, Gorgoulis Vassilis G, Tzioufas Athanasios G
Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Ann Rheum Dis. 2024 Feb 15;83(3):342-350. doi: 10.1136/ard-2023-224467.
Age is the strongest risk factor of giant cell arteritis (GCA), implying a possible pathogenetic role of cellular senescence. To address this question, we applied an established senescence specific multimarker algorithm in temporal artery biopsies (TABs) of GCA patients.
75(+) TABs from GCA patients, 22(-) TABs from polymyalgia rheumatica (PMR) patients and 10(-) TABs from non-GCA/non-PMR patients were retrospectively retrieved and analysed. Synovial tissue specimens from patients with inflammatory arthritis and aorta tissue were used as disease control samples. Senescent cells and their histological origin were identified with specific cellular markers; IL-6 and MMP-9 were investigated as components of the senescent associated secretory phenotype by triple costaining. GCA or PMR artery culture supernatants were applied to fibroblasts, HUVECs and monocytes with or without IL-6R blocking agent to explore the induction of IL-6-associated cellular senescence.
Senescent cells were present in GCA arteries at higher proportion compared with PMR (9.50% vs 2.66%, respectively, p<0.0001) and were mainly originated from fibroblasts, macrophages and endothelial cells. IL-6 was expressed by senescent fibroblasts, and macrophages while MMP-9 by senescent fibroblasts only. IL-6(+) senescent cells were associated with the extension of vascular inflammation (transmural inflammation vs adventitia limited disease: 10.02% vs 4.37%, respectively, p<0.0001). GCA but not PMR artery culture supernatant could induce IL-6-associated senescence that was partially inhibited by IL-6R blockade.
Senescent cells with inflammatory phenotype are present in GCA arteries and are associated with the tissue inflammatory bulk, suggesting a potential implication in disease pathogenesis.
年龄是巨细胞动脉炎(GCA)最强的风险因素,这意味着细胞衰老可能在发病机制中发挥作用。为解决这一问题,我们在GCA患者的颞动脉活检(TABs)中应用了一种既定的衰老特异性多标志物算法。
回顾性收集并分析了75份(+)GCA患者的TABs、22份(-)风湿性多肌痛(PMR)患者的TABs和10份(-)非GCA/非PMR患者的TABs。来自炎性关节炎患者的滑膜组织标本和主动脉组织用作疾病对照样本。用特异性细胞标志物鉴定衰老细胞及其组织学来源;通过三重共染色研究IL-6和MMP-9作为衰老相关分泌表型的组成部分。将GCA或PMR动脉培养上清液应用于有或无IL-6R阻断剂的成纤维细胞、人脐静脉内皮细胞(HUVECs)和单核细胞,以探索IL-6相关细胞衰老的诱导情况。
与PMR相比,GCA动脉中衰老细胞的比例更高(分别为9.50%和2.66%,p<0.0001),且主要来源于成纤维细胞、巨噬细胞和内皮细胞。衰老的成纤维细胞和巨噬细胞表达IL-6,而只有衰老的成纤维细胞表达MMP-9。IL-6(+)衰老细胞与血管炎症的扩展相关(透壁炎症与外膜局限性疾病:分别为10.02%和4.37%,p<0.0001)。GCA而非PMR动脉培养上清液可诱导IL-6相关衰老,IL-6R阻断可部分抑制这种衰老。
具有炎性表型的衰老细胞存在于GCA动脉中,并与组织炎症程度相关,提示其在疾病发病机制中可能具有潜在作用。